news Roche targets becoming top 3 obesity player as experimental drug enters late-stage trial By AdminSeptember 25, 2025Less 1 min read106 Views0 Roche Pharmaceuticals’ CEO told investors she was “serious” about the goal of becoming a top 3 obesity player. ShareTweetPinShare Previous PostMagellanic penguins released back to the sea in Uruguay Next PostJimmy Kimmel’s Return Draws 6.2 Million Viewers, Ratings Show Leave a Reply Your email address will not be published. Required fields are marked * Save my name, email, and website in this browser for the next time I comment. You May Also Like February 3, 20260 Comments Rory Guilday’s long road from chemotherapy to the Olympics September 25, 20250 Comments U.S. expands tariff dragnet to masks, syringes and robotics in sweeping import probe November 24, 20250 Comments Here’s what’s in the RAISE Act, a state-level AI bill opposed by Trump and industry leaders October 5, 20250 Comments Ian Roberts, Des Moines Superintendent, Had a Story Too Good to Be True
September 25, 20250 Comments U.S. expands tariff dragnet to masks, syringes and robotics in sweeping import probe
November 24, 20250 Comments Here’s what’s in the RAISE Act, a state-level AI bill opposed by Trump and industry leaders